• Jeffrey M Haynes, David A Kaminsky, and Gregg L Ruppel.
• Pulmonary Function Laboratory, Elliot Health System, Manchester, New Hampshire. jhaynes@elliot-hs.org.
• Respir Care. 2023 Jul 1; 68 (7): 889913889-913.

AbstractPulmonary function testing (PFT) has a long and rich history in the definition, diagnosis, and management of COPD. For decades, spirometry has been regarded as the standard for diagnosing COPD; however, numerous studies have shown that COPD symptoms, pathology, and associated poor outcomes can occur, despite normal spirometry. Diffusing capacity and imaging studies have called into question the need for spirometry to put the "O" (obstruction) in COPD. The role of exercise testing and the ability of PFTs to phenotype COPD are reviewed. Although PFTs play an important role in diagnosis, treatment decisions are primarily determined by symptom intensity and exacerbation history. Although a seminal study positioned FEV1 as the primary predictor of survival, numerous studies have shown that tests other than spirometry are superior predictors of mortality. In years past, using spirometry to screen for COPD was promulgated; however, this only seems appropriate for individuals who are symptomatic and at risk for developing COPD.Copyright © 2023 by Daedalus Enterprises.

15 keywords...

hide…